Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kempharm Inc

(NASDAQ: KMPH)
Add to Portfolio
-0.03 (-3.61%)
as of 14:26 EDT

KemPharm to Participate in the Oppenheimer Fall Summit

GlobeNewswire via COMTEX - Tue Sep 17, 08:30AM EDT
KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president and chief executive officer, Travis C. Mickle, Ph.D., will host(full story)
KMPH: 0.80 (-0.03)

KemPharm to Present at the 21st Annual Global

GlobeNewswire via COMTEX - Thu Sep 05, 07:30AM EDT
KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that its president and chief executive officer, Travis C. Mickle, Ph.D., will prese(full story)
KMPH: 0.80 (-0.03)

KemPharm Announces Entry into Definitive Collaboration

GlobeNewswire via COMTEX - Wed Sep 04, 08:01AM EDT
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales(full story)
KMPH: 0.80 (-0.03), PTCI: 0.5500 (+0.1500)

KemPharm Reports Second Quarter 2019 Results

GlobeNewswire via COMTEX - Tue Aug 13, 05:00PM EDT
KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and financial results for the quarter ended June 30, 2019.(full story)
KMPH: 0.80 (-0.03)

KemPharm to Present at Upcoming Investor Conferences

GlobeNewswire via COMTEX - Tue Mar 05, 07:29AM EST
KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that management will present at several investor conferences during March 2019.(full story)
KMPH: 0.80 (-0.03)